Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02703272
Brief Title: A Safety and Efficacy Study of Ibrutinib in Pediatric and Young Adult Participants With Relapsed or Refractory Mature B-cell Non-Hodgkin Lymphoma

First Submitted : March 3, 2016
First Submitted that Met QC Criteria : March 3, 2016
First Posted : March 9, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : November 14, 2019
Last Update Posted : November 15, 2019